Pekin Hardy Strauss Inc. lowered its position in shares of Cameco Corporation (NYSE:CCJ - Free Report) TSE: CCO by 3.4% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 336,940 shares of the basic materials company's stock after selling 11,918 shares during the quarter. Cameco accounts for about 1.7% of Pekin Hardy Strauss Inc.'s investment portfolio, making the stock its 4th biggest holding. Pekin Hardy Strauss Inc. owned about 0.08% of Cameco worth $13,868,000 at the end of the most recent reporting period.
Other large investors have also recently bought and sold shares of the company. Larson Financial Group LLC grew its holdings in shares of Cameco by 37.4% in the 4th quarter. Larson Financial Group LLC now owns 830 shares of the basic materials company's stock valued at $43,000 after acquiring an additional 226 shares in the last quarter. Two Sigma Investments LP boosted its position in Cameco by 0.5% during the fourth quarter. Two Sigma Investments LP now owns 50,438 shares of the basic materials company's stock valued at $2,592,000 after purchasing an additional 238 shares during the last quarter. Highview Capital Management LLC DE grew its stake in Cameco by 5.0% in the fourth quarter. Highview Capital Management LLC DE now owns 6,246 shares of the basic materials company's stock valued at $321,000 after purchasing an additional 300 shares in the last quarter. MinichMacGregor Wealth Management LLC increased its position in shares of Cameco by 5.0% during the 1st quarter. MinichMacGregor Wealth Management LLC now owns 6,372 shares of the basic materials company's stock worth $262,000 after purchasing an additional 304 shares during the last quarter. Finally, Freedom Investment Management Inc. increased its position in shares of Cameco by 5.3% during the 4th quarter. Freedom Investment Management Inc. now owns 6,230 shares of the basic materials company's stock worth $320,000 after purchasing an additional 312 shares during the last quarter. Institutional investors own 70.21% of the company's stock.
Cameco Trading Up 1.9%
Shares of NYSE:CCJ opened at $73.02 on Monday. Cameco Corporation has a 12-month low of $35.00 and a 12-month high of $75.42. The business has a 50 day moving average of $59.91 and a 200-day moving average of $50.97. The company has a quick ratio of 1.26, a current ratio of 2.70 and a debt-to-equity ratio of 0.15. The stock has a market cap of $31.79 billion, a PE ratio of 182.55 and a beta of 1.03.
Cameco (NYSE:CCJ - Get Free Report) TSE: CCO last released its quarterly earnings results on Thursday, May 1st. The basic materials company reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.07). The firm had revenue of $549.58 million during the quarter, compared to the consensus estimate of $890.07 million. Cameco had a net margin of 7.50% and a return on equity of 4.47%. The business's revenue for the quarter was up 24.4% compared to the same quarter last year. During the same quarter last year, the firm earned $0.13 earnings per share. As a group, equities research analysts forecast that Cameco Corporation will post 1.27 earnings per share for the current year.
Wall Street Analysts Forecast Growth
CCJ has been the topic of a number of recent analyst reports. Wall Street Zen upgraded shares of Cameco from a "sell" rating to a "hold" rating in a report on Tuesday, May 13th. Stifel Nicolaus started coverage on shares of Cameco in a research note on Wednesday, March 12th. They set a "buy" rating on the stock. Raymond James Financial reaffirmed an "outperform" rating on shares of Cameco in a report on Wednesday, June 18th. Royal Bank Of Canada lifted their price target on Cameco from $90.00 to $100.00 and gave the stock an "outperform" rating in a report on Friday, June 20th. Finally, Glj Research reissued a "buy" rating and set a $75.27 price target on shares of Cameco in a research report on Thursday, June 12th. One equities research analyst has rated the stock with a hold rating, ten have assigned a buy rating and three have assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and an average target price of $80.65.
View Our Latest Stock Report on CCJ
About Cameco
(
Free Report)
Cameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.
Featured Stories
Want to see what other hedge funds are holding CCJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cameco Corporation (NYSE:CCJ - Free Report) TSE: CCO.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cameco, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cameco wasn't on the list.
While Cameco currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.